GlycoMimetics, Inc(NASDAQ:GLYC) 
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. The company's drug candidate include rivipansel, a pan-selectin antagonist for the treatment ...
Website: http://www.glycomimetics.com
Founded: 2003
Full Time Employees: 57
Founder: Rachel K. King
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-12-12
P
O 0.26
H 0.28
L 0.25
C 0.25
V 953,024
10EMA 0.25
20EMA 0.25
60EMA 0.25
120EMA 0.25
250EMA 0.25